Event-Related Potential (ERP) Components in Clinical Diagnosis
Stopped early
Conditions studied: Alzheimer Disease, Dementia, Mild, Mild Cognitive Impairment
In brief
In this study, the investigators will use a novel electroencephalogram (EEG) system that participants will wear during a single in-person research session to investigate whether ERPs are now ready for validation as a tool clinicians can easily implement to increase diagnostic accuracy and confidence. This EEG will not be used to treat, cure, mitigate or diagnosis any disease and there will be no safety or efficacy data collected about the machine for any purpose including support of FDA submission. The investigators will compare the ERP data to that of neuropsychological testing in order to determine the degree of correlation between these two measures. Questionnaires on cognition, mood, and fluency will be administered prior to the EEG to establish a baseline. ERP data from the EEG session will be compared with the results of the neuropsychological battery in order to determine whether the implementation of ERPs in the existing workflow of clinicians can aid in diagnostic accuracy, thus altering clinical management.
Key facts
- Study ID
- NCT05673759
- Run by
- Boston University
- People needed
- 148
- Starts
- 2023-03-06
- Expected to finish
- 2025-05-01
- Last updated by the study team
- 2025-12-16
Who can join
Age: 20 and older, up to 90. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- For Mild Alzheimer Disease (AD) dementia
- Meets probable AD dementia National Institute on Aging and Alzheimer's Association (NIA-AA) criteria
- 50-90 years old
- Mini-Mental State Examination (MMSE) 20-27
- Performance on delayed recall and recognition memory worse than 1.5 standard deviation (SD) for age and education
- Performance on delayed recall and recognition memory worse than 1.5 SD for age \& education in at least one other cognitive domain (e.g., language, executive functioning) based on other tests in our neuropsychological test battery.
- Dr. Turk and Dr. Budson will confirm all mild AD dementia diagnoses
- For Mild cognitive impairment (MCI)
- MCI due to any etiology 50-90 years old
- MMSE > 23
- Performance on delayed recall and recognition memory worse than 1.0 SD for age \& education adjusted norms
- Dr. Turk and Dr. Budson will confirm all MCI diagnoses
- For Healthy older adults
- 50-90 years old
- Functioning normally in occupation determined by self-report
- For Healthy younger adults
- 20-50 years old
- Functioning normally in occupation determined by self-report
You may not qualify if…
- A clinically significant problem of any of the following conditions:
- depression
- heavy alcohol or drug use
- cerebrovascular disease
- a different degenerative disease (e.g., fronto-temporal dementia, Parkinson's disease)
- any medical condition whose severity could significantly impair cognition (e.g., organ failure)
- on any antipsychotic or epilepsy medication
- Unable to understand the consent form
Where it is running
- BU Alzheimer Disease Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.